Some aspects of the relationship between oral contraceptives, lipid abnormalities, and cardiovascular disease.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1990-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9378(90)90581-QPMID 2196808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk Factors for Ischaemic Heart Disease in Men and Women: Results of the 19-Year Follow-up of the Stockholm Prospective Study

  2009cited by this paper
• Triglycerides--main lipid risk factor for cardiovascular disease in women?

  2009cited by this paper
• Mortality among oral contraceptive users.

  1990cited by this paper
• Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism.

  1990cited by this paper
• A comparison of the effects of ethinyl estradiol and estradiol valerate on serum and lipoprotein lipids.

  1988cited by this paper
• Serum lipids and lipoproteins in pregnancies associated with emesis gravidarum.

  1987cited by this paper
• Cardiovascular risk factors from birth to 7 years of age: the Bogalusa Heart Study. Serum lipids and lipoproteins.

  1987cited by this paper
• Mortality among oral contraceptive users

  1987cited by this paper
• Effects of Cyproterone Acetate (CPA) on Serum Lipoproteins When Administered Alone and in Combination with Ethinyl Estradiol (EE)

  1987cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques.

  1987cited by this paper
• The triglyceride issue: a view from Framingham.

  1986cited by this paper
• A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study.

  1986cited by this paper
• The relative fatty acid composition of serum lecithin and cholesterol ester: influence of an estrogen-progestogen regimen in climacteric women.

  1986cited by this paper
• Progestogens and lipid metabolism.

  1986cited by this paper
• Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study.

  1985cited by this paper
• Monitoring trends in cardiovascular disease and risk factors: the WHO "Monica" project.

  1985cited by this paper
• The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.

  1985cited by this paper
• Hypertriglyceridaemia and hypercoagulability.

  1983cited by this paper
• Lipid metabolic studies in oophorectomized women. Effects induced by the addition of norethisterone acetate to two different oestrogens on serum individual phospholipids and serum lecithin fatty acid composition.

  1981cited by this paper
• Effects Induced by Two Different Estrogens on Serum Individual Phospholipids and Serum Lecithin Fatty Acid Composition

  1981cited by this paper
• Effect of cholesterol on production of thromboxane b2 by platelets in vitro.

  1980cited by this paper
• Letter: Trisomy-20 syndrome in man.

  1976cited by this paper
• Risk factors for myocardial infarction in young women.

  1976cited by this paper

• Contraception hormonale féminine

  2006cites this paper
• RIN 0905-AB67 Food Labeling: Health Claims and Label Statements; Dietary Saturated Fat and Cholesterol and Coronary Heart Disease

  2005cites this paper
• Contracepción hormonal femenina

  1999cites this paper
• The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.

  1999cites this paper
• Uniqueness of oral contraceptive progestins.

  1998cites this paper
• Contraception hormonale féminine

  1998cites this paper
• Increased fibrin formation in blood in women above the age of 30 who are both oral contraceptive users and smokers

  1996cites this paper
• Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.

  1994cites this paper
• A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol.

  1994cites this paper
• Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.

  1993cites this paper
• Norgestimate: a clinical overview of a new progestin.

  1992cites this paper